Press release
Neurogenetic Testing Market Insights 2024: Emerging Technologies and Global Expansion
Neurogenetic Testing Market Insights
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=16131&type=smp
According to The Business Research Company's, The neurogenetic testing market size has grown rapidly in recent years. It will grow from $0.54 billion in 2023 to $0.61 billion in 2024 at a compound annual growth rate (CAGR) of 13.3%. The growth in the historic period can be attributed to increased prevalence of neurological disease cases, increase research in life science domain, increasing prevalence of parkinson's disease, increased cases of cancer, and rising awareness among healthcare professionals.
The neurogenetic testing market size is expected to see rapid growth in the next few years. It will grow to $1.02 billion in 2028 at a compound annual growth rate (CAGR) of 13.6%. The growth in the forecast period can be attributed to expanding applications in personalized medicine, rise in chronic diseases, increased number of hospitals, increased number of diagnostic laboratories and growing demand for early disease detection. Major trends in the forecast period include technological advancement, greater adoption of non-invasive testing methods, new product development, strategic collaborations, and the emergence of novel biomarkers for neurological conditions.
Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/neurogenetic-testing-global-market-report
Market Drivers and Trends:
The rising cases of cardiovascular diseases are expected to propel the growth of the nuclear medicine radioisotope market going forward. Cardiovascular diseases refer to a group of diseases that affect the heart and blood vessels. The rising cases of cardiovascular diseases are due to sedentary lifestyles, poor dietary habits, increasing rates of obesity, and aging populations. The nuclear medicine radioisotopes are invaluable in diagnosing, evaluating, and managing cardiovascular diseases with detailed insights into cardiac function, perfusion, and tissue viability, which are essential for accurate diagnosis and effective treatment planning. For instance, in May 2022, according to the Centers for Disease Control and Prevention, a US-based governmental organization, the prevalence of coronary heart disease among adults aged 18 and over stood at 4.6% in 2020, experiencing a slight uptick to 4.9% in 2021. Therefore, the rising cases of cardiovascular diseases are driving the growth of the nuclear medicine radioisotope market.
Major companies operating in the neurogenetic testing market are developing innovative products, such as whole-genome sequencing, to enhance the accuracy and scope of genetic analysis, enabling more comprehensive and personalized testing for neurological disorders. Whole-genome sequencing (WGS) is a comprehensive genetic testing method that involves determining the complete DNA sequence of an individual's entire genome. For instance, in March 2024, Nucleus Genomics, a US-based company that provides genetic analysis, launched a DNA analysis product. Through this platform empower people with a deeper understanding of their genetic predispositions, facilitating informed decisions about their health and well-being. With cutting-edge technology and expert genetic counseling services, Nucleus Genomics is set to redefine the landscape of genetic testing, bringing the power of whole-genome sequencing directly into the hands of individuals and revolutionizing the field of genomic medicine.
Key Benefits for Stakeholders:
• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.
Major Key Players of the Market:
Thermo Fisher Scientific Inc., Mayo Clinic, Roche Diagnostics Corporation, Laboratory Corporation, Quest Diagnostics Incorporated, Eurofins Scientific Inc., Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Exact Sciences Corporation, Myriad Genetics Inc., BioReference Laboratories Inc., Connecticut Children's, Invitae Corp., Ambry Genetics Corporation, Fulgent Genetics Inc., Blueprint Genetics Inc., GeneDx LLC, Pacific Biosciences of California Inc., MedGenome Labs, CENTOGENE, Baylor Genetics, Victorian Clinical Genetics Services
Neurogenetic Testing Market 2024 Key Insights:
• The neurogenetic testing market size is expected to see rapid growth in the next few years. It will grow to $1.02 billion in 2028 at a compound annual growth rate (CAGR) of 13.6%.
• Rising Prevalence Of Neurological Disorders Fuels Demand For Neurogenetic Testing
• Innovative Products Driving Growth In The Neurogenetic Testing Market
• North America was the largest region in the neurogenetic testing market in 2023
We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/Customise?id=16131&type=smp
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Neurogenetic Testing Market Insights 2024: Emerging Technologies and Global Expansion here
News-ID: 3709905 • Views: …
More Releases from The Business Research Company
Key Factor Supporting Global Helpdesk Automation Market Development in 2025: Imp …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Helpdesk Automation Industry Market Size Be by 2025?
The market size for helpdesk automation has experienced exponential growth recently. It's projected to increase from $6.14 billion in 2024 to $8.13 billion in 2025, with a compound annual growth rate (CAGR) of 32.4%. Factors contributing to this…
Growth Of The Graph Technology Market Driven By The Expansion Of Internet of Thi …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Graph Technology Market Through 2025?
The market size for graph technology has experienced substantial growth in the recent past. Its expansion is anticipated to rise from $5.26 billion in 2024 to $6.4 billion in 2025, with a compound annual growth rate (CAGR)…
2025-2034 Generative Design Software Market Outlook: Key Drivers, Emerging Chall …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Generative Design Software Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent years, the market size for generative design software has seen a swift expansion. This growth trajectory is projected to continue, rising from $2.25 billion in 2024 to $2.66 billion in 2025, representing…
Widespread Internet Access Fuels The Growth Of Generative AI In Movies Market Em …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Generative AI In Movies Market Size Growth Forecast: What to Expect by 2025?
The market size for generative ai in movies has experienced significant expansion in the past few years. The growth is projected to increase from $0.32 billion in 2024 to $0.4 billion in 2025 with a compound…
More Releases for Neurogenetic
Emerging Trends to Drive Neurogenetic Testing Market Growth at 13.5% CAGR Throug …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Neurogenetic Testing Market Size Growth Forecast: What to Expect by 2025?
Recently, there has been a swift development in the neurogenetic testing market size. The market is set to expand from $0.61 billion in 2024 to $0.7 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 13.9%.…
Neurogenetic Testing Market Anticipated To Witness Robust Growth, Surpassing $1. …
The Neurogenetic Testing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Neurogenetic Testing Market Size and Its Estimated Growth Rate?
The neurogenetic testing market has seen fast growth. It will grow from $0.61 billion in 2024 to $0.7 billion in 2025 at…
Neurogenetic Testing Market Growth Outlook, Exploring Advances, Emerging Technol …
Overview of the Neurogenetic Testing Market
The global neurogenetic testing market has witnessed substantial growth over the past decade, driven by the increasing prevalence of neurological disorders with genetic origins and rapid advancements in genetic testing technologies. This growth is primarily propelled by rising awareness about hereditary neurological diseases such as Huntington's disease, amyotrophic lateral sclerosis (ALS), and various forms of hereditary epilepsy, coupled with increasing demand for personalized medicine…
Rising Prevalence Of Neurological Disorders Fuels Demand For Neurogenetic Testin …
Which drivers are expected to have the greatest impact on the over the neurogenetic testing market's growth?
The increasing prevalence of neurological disorders is also expected to propel the growth of the neurogenetic testing market. These disorders affect the nervous system and can arise from genetic factors, infections, trauma, or degeneration. Neurogenetic testing offers valuable insights into the genetic risk factors of these conditions, guiding treatment choices and improving patient care.…
Neurogenetic Testing Market Poised for 13.5 % Growth, Set to Hit $21 Billion by …
How Is the Neurogenetic Testing Market Projected to Grow, and What Is Its Market Size?
The market size for neurogenetic testing has expanded considerably in the last few years. Its expansion will continue, with an increase from $0.61 billion in 2024 to $0.7 billion in 2025, reflecting a compound annual growth rate (CAGR) of 13.9%. Factors contributing to the growth during the historic period include a surge in neurological disease…
Neurogenetic Testing Market: Size, Share, Competitive Landscape, Current Industr …
The Neurogenetic Testing market research report is proficient and top to bottom research by specialists on the current state of the industry. This statistical surveying report gives the most up to date industry information and industry future patterns, enabling you to distinguish the items and end clients driving income development and benefit. It centres around the real drivers and restrictions for the key players and present challenge status with development…
